Colon carcinoma cell glycolipids,integrins, and other glycoproteins mediate adhesion to HUVECs under flow

This study was undertaken toinvestigate the molecular constituents mediating LS174T colonadenocarcinoma cell adhesion to 4-h TNF--stimulated human umbilicalvein endothelial cells (HUVECs) under flow. At 1 dyn/cm²,~57% of cells rolled and then became firmly adherent, whereas otherscontinuously rolled on endothelium. Initial cell binding was primarilymediated by endothelial E-selectin. By using neuraminidase, glycolipidbiosynthesis inhibitord,l-threo-1-phenyl-2-hexadecanoylamino-3-pyrrolidino-1-propanol · HCl,trypsin, and flow cytometry, LS174T cells were shown to express sialylLewis^x (sLe^x)- anddi-sLe^x-decorated, but not sLe^a-decorated,glycolipid and glycoprotein ligands for E-selectin. The cellspreferentially employed sialylated glycoproteins over glycolipids inadhesion as measured by conversion of rolling to firm adhesion,resistance to detachment by increased shear stress, and rollingvelocity. However, a nonsialylated E-selectin counterreceptor alsoexists. Furthermore, LS174T ₂, ₆, and₁ integrins support a minor pathway in adhesion toHUVECs. Finally, tumor cell attachment specifically increases HUVECendocytosis of E-selectin. Altogether, the data indicate the complexityof carcinoma cell-endothelium adhesion via sialylated glycoconjugates,integrins, and their respective counterreceptors.